2nd Quarter - Report

ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
—
Expenses
$460,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Country of origin for federal contracts (no assigned legislation) Untellectual property protections in Latin America

LobbyistCovered position, as disclosed
JAMES LAUBNER New —
BRADLEY ALLEN ROSSIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Taxation/Internal Revenue Code TAX

Reform of tax code and possible timing of any such reform bill (no bill number yet)

LobbyistCovered position, as disclosed
BRADLEY ALLEN ROSSIN —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); SENATE

Copyright/Patent/Trademark CPT

H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 development of antibiotics Strengthening incentives for developing and protecting intellectual property (no assigned legislation)S. 214, H.R.245, H.R.2024, S.1013, S.866, S.Amd. 628 and related legislative proposals regarding possible restrictions on patent settlements Data exclusivity for patented biological products (No assigned legislation)

LobbyistCovered position, as disclosed
CARRIE HARNEY —
THERESA JOLIVETTE —
JACQUELINE POMFRET KIRBY —
BELA SASTRY —
HEATHER STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Bills named: S. 866 (113th), S. 1013 (113th), S. 1734 (113th), H.R. 2182 (113th), H.R. 245 (113th), H.R. 2024 (113th), S. 214 (113th)

Health Issues HCR

H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) as enacted in Pub. L. No. 112-144 development of antibiotics H.R. 1919, S.959, S.957 and related legislative proposals - Drug safety and supply chain protectionsFederal purchases under the Trade Agreements Act Federal revenues, entitlement reform, and deficit reduction regarding ongoing fiscal talks and sequestration Oversight and possible amendment or reform of federal 340B pharmaceutical purchasing program

LobbyistCovered position, as disclosed
CARRIE HARNEY —
THERESA JOLIVETTE —
ANDREW KAPLAN —
JACQUELINE POMFRET KIRBY —
BRADLEY ALLEN ROSSIN —
BELA SASTRY —
HEATHER STRAWN —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Bills named: H.R. 1919 (113th), S. 957 (113th), S. 1734 (113th), H.R. 2182 (113th), S. 959 (113th)

Medicare/Medicaid MMM

H.R. 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - Medicare and Medicaid reform including issues related to adherence programs and non-interference Medicaid rebate formula (no assigned legislation)

LobbyistCovered position, as disclosed
THERESA JOLIVETTE —
JACQUELINE POMFRET KIRBY —
BELA SASTRY —
HEATHER STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; U.S. Trade Representative (USTR)

Bills named: H.R. 3590 (113th)

Consumer Issues/Safety/Products CSP

H.R.1919, S.959, S.957 and related legislative proposals - Drug safety and supply chain protections

LobbyistCovered position, as disclosed
CARRIE HARNEY —
THERESA JOLIVETTE —
JACQUELINE POMFRET KIRBY —
BELA SASTRY —
HEATHER STRAWN —

Contacted: Commerce, Dept of (DOC); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1919 (113th), S. 959 (113th), S. 957 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.